Nanosonics at the Threshold: CORIS Launch Marks a Multi-Platform Inflection

Trophon's cash engine funds a strategic pivot, with record placements and a new buyback.

NAN.AX · Earnings Call · 2026-08-24

The Trophon Engine Delivers

In FY26, Nanosonics reported a solid set of results, with constant currency revenue up 6% and EBIT up 21%, underpinned by disciplined cost control. The core annuity revenue stream grew 4% reported (8% constant currency) to $141.8M, while the cumulative installed base expanded 6% to 39,230 units. Record placements of over 4,200 units, including a 32% jump in North American upgrades, demonstrate the strength of the trophon franchise. As Michael Kavanagh put it, “the trophon definitely remains a highly profitable engine that gives us the flexibility to fund CORIS, maintain a debt-free balance sheet and continue investing for the long term.” — Michael Kavanagh, Chief Executive Officer and President · 2026-08-24 The company also recovered $2.5M in IEEPA tariff refunds, a theme that resonates globally as tariff noise dominated earnings calls. Weather events in Q3 temporarily dampened consumables, but volumes rebounded in Q4, confirming the dip was transient.

CORIS: The Strategic Pivot

The defining moment is the imminent commercial launch of CORIS in the first half of FY27. After years of R&D and regulatory progress, the company is now moving from a single-platform to a multi-platform infection prevention company. This is a genuine inflection point, not just incremental. As Kavanagh noted:

we are now certainly entering what we consider a defining period of new growth as we now move from a single platform to becoming a multi-platform infection prevention company.
Michael Kavanagh, Chief Executive Officer and President · 2026-08-24

The CORIS opportunity is substantial — around 60 million endoscope procedures annually in target markets. The economics are compelling: capital price 3-5x trophon, cycles per day 3-4x, and price per cycle 4-6x higher. With gross margins similar to trophon's consumables, the installed-base model promises the same sort of annuity quality that has made trophon so profitable. The CORIS launch is backed by a deliberate step-up in investment, with the majority of incremental OpEx going into regional sales and installation support. Management expects FY27 revenue of $220-228M (8-12% growth) with CORIS contributing low single-digit millions. The connectivity subscription model, teased in prior calls, is now coming into focus. In August 2025, Michael noted: “there'll be an initial cost for the upgrade. And then we expect an annual subscription for the DICOM connectivity in the cloud.” — Michael C. Kavanagh, Chief Executive Officer · 2025-08-26 That recurring revenue stream is exactly the kind of cash generation the market has come to expect from Nanosonics.

Capital Returns and Guidance

The balance sheet remains pristine with $155.2M cash and a debt-free position. Following a $20M buyback completed in FY26, the company announced a further $40M buyback. This reflects confidence in the outlook and a disciplined capital allocation strategy. The FY27 guidance implies strong continued growth in trophon, with operating leverage expected to improve further. Prior calls had flagged the CORIS readiness and the potential for a step-up in OpEx. In the February 2026 call, Jason Burriss confirmed that “we continue to try and drive the operating leverage, which we've been able to achieve in previous halves.” — Jason Burriss, CFO · 2026-02-24 The current call delivers on that promise while finally putting CORIS on the launch pad. The real story is the transition: a mature cash cow funding a second growth engine. The market has rewarded this with a resilient share price, and the buyback signals further confidence.